rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Oragenics Inc.

OGEN · NYSE American

Health CareBiotechnologyNot moving yet

OGEN stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 24.1% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$593
Officials’ trades on record
0
Institutions holding
16 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$71K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 1
WhoDidSharesTraded
Fred TellingDirectorsold210at $0.944612 Dec 2025filed 22 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16-2 on the quarter
New · exited2 · 4
Reported value$39K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202623,685$14K-41,387−63.6%
25 LLCnew · filed 28 Jul 202623,160$13K+23,160
JANE STREET GROUP, LLCnew · filed 14 Aug 202612,771$7,414+12,771
Tower Research Capital LLC (TRC)unchanged · filed 11 Aug 20264,548$2,64100.0%
St. Johns Investment Management Company, LLCadded · filed 4 Aug 20261,924$1,117+1,724+862.0%
BlackRock, Inc.unchanged · filed 7 Aug 2026703$40800.0%
UBS Group AGreduced · filed 13 Aug 2026642$373-4,563−87.7%
WELLS FARGO & COMPANYunchanged · filed 14 Aug 202634$2000.0%
HARBOUR INVESTMENTS, INC.unchanged · filed 12 Aug 202634$2000.0%
SBI Securities Co., Ltd.added · filed 23 Jul 202623$13+12+109.1%
30 Jun 2025 – 30 Jun 2026
151718Jun 25Sep 25Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

John Spencer Company insiderChief Financial Officer · last 1 Jul 20260 · 0
Fred Telling Company insiderDirector · last 12 Dec 202517 · 4
Alan W. Dunton Company insiderDirector · last 11 Dec 20251 · 16
Charles L. Pope Company insiderDirector · last 11 Dec 20250 · 1
Janet Huffman Company insiderCEO and CFO · last 11 Dec 20250 · 0
John P. Gandolfo Company insiderDirector · last 11 Dec 20250 · 0
Natasha Giordano Company insiderDirector · last 11 Dec 20250 · 0
Robert C. Koski Company insiderDirector · last 11 Dec 20258 · 12
Odyssey Health, Inc. Company insider10% owner · last 18 Jun 20250 · 4
Bruce A. Cassidy, Sr. Company insiderDirector · last 19 Sep 20240 · 0
J. Michael Redmond Company insiderPresident · last 19 Sep 20240 · 0
Kimberly M. Murphy Company insiderDirector · last 19 Sep 20240 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 13 Mar 20261.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$4.4M

Analyst forecasts

No analyst forecasts yet.